शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEAmerise Biosciences Ltd· Industrial ProductsHighNeutral
Announced Mon, 2 Feb, 2026 · 16:34 IST

PFA

Net loss reportedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.5%Reaction day
₹0.66
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+3.7%+0.8% vs market
Plastic Products - Industrial peers, median of 40sector+2.5%+2.0% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 2.0 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.5+3.7+0.8+2.5+2.0
Next day
+19.7+5.1+14.6+3.2+16.5
2d
+27.3+4.0+23.2+2.7+24.5
3d
+15.2+3.2+11.9+2.0+13.2
4d
+18.2+5.9+12.3+4.6+13.6
5d
+21.2+6.9+14.3+6.5+14.7
1w
+3.0+5.9-2.8+7.3-4.3
15d
+9.1+2.1+7.0+4.8+4.3
1m
-24.2-3.5-20.8-3.1-21.1
2m
+0.0-4.2+4.2-6.0+6.0
3m
+9.1+10.9-1.8+0.5+8.6
UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 40Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amerise Biosciences (formerly Amradeep Industries) announced unaudited results for the quarter and nine months ended 31 December 2025. The company reported zero revenue from operations, with total income of Rs 4.49 lakh in Q3 FY26 (entirely from 'other income') and Rs 17.60 lakh for 9M FY26. Profit after tax was Rs 0.97 lakh for Q3, but the company posted a loss of Rs 4.07 lakh for the nine-month period, narrower than the Rs 9.83 lakh loss in the corresponding 9M of the previous year. Total expenses for 9M FY26 stood at Rs 21.67 lakh. The board also accepted the resignation of Mr. Dinesh Rathod as Whole-time Director & CFO (citing pre-occupation with other work) and appointed 25-year-old Mr. Albert Hines, with about 3 years of finance experience, as the new Whole-time Director and CFO effective 2 February 2026. The statutory auditors (Bipin & Co.) issued an unmodified limited review report with no qualifications.

Likely market impact

The company continues to generate no operating revenue and is dependent on 'other income' to stay afloat, with negative other equity of Rs 122.71 lakh against share capital of Rs 660.69 lakh — investors should view this as a high-risk, micro-cap situation. The CFO change and the very young, lightly experienced replacement could raise governance concerns for shareholders.